CAS 102767-28-2: Levetiracetam
Description:Levetiracetam is an antiepileptic drug primarily used to treat epilepsy and seizures. It is classified as a pyrrolidine derivative and is known for its unique mechanism of action, which involves binding to the synaptic vesicle protein 2A (SV2A), thereby modulating neurotransmitter release. Levetiracetam is characterized by its high solubility in water and moderate lipophilicity, which facilitates its absorption and distribution in the body. The compound has a molecular formula of C8H14N2O2 and a relatively low molecular weight. It is typically administered in the form of tablets, oral solution, or intravenous injection, allowing for flexible dosing options. Levetiracetam is generally well-tolerated, with a side effect profile that may include dizziness, fatigue, and behavioral changes. Importantly, it does not require routine monitoring of blood levels, making it a convenient option for many patients. Its efficacy in controlling partial-onset seizures and its favorable pharmacokinetic properties contribute to its widespread use in clinical practice.
Formula:C8H14N2O2
InChI:InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1
InChI key:InChIKey=HPHUVLMMVZITSG-LURJTMIESA-N
SMILES:O=C(N)C(N1C(=O)CCC1)CC
- Synonyms:
- (2S)-2-(2-oxopyrrolidin-1-yl)butanamide
- (S)-1-pyrrolidineacetamid
- 1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (S)-
- Etiracetamum [INN-Latin]
- (S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
- LEVITIRACETAM
- 1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (αS)-
- Keppra
- (s)-2-(2-oxopyrrolidin-1-yl)butanamide
- alpha-Ethyl-2-oxo-1-pyrrolidineacetamide
- See more synonyms
- 1-Pyrrolidineacetamide
- UCB-L 059
- Levetiracetamum [INN-Latin]
- UCB-6474
- UCB-L 059
- alpha-ethyl-2-oxo-
- Levetiracetam
- (αS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide
- UCB 6474
- Name:(S)-2-(2-Oxopyrrolidin-1-yl)butanamide (Levetiracetam)
- (2R)-2-(2-oxopyrrolidin-1-yl)butanamide
- Levetiracetame
- Levetiracetam [INN]
- (+-)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide